LYNA was even more effective when serving as a companion -- pathologists performing simulated diagnoses found that the deep learning tech made their work easier. It not only reduced the rate of missed micro-metastases by a "factor of two," it cut the inspection time in half to a single minute. This immediate approach would only have so much effectiveness in the field, since it would be looking for late-stage breast cancer where there's no known solution.